tiprankstipranks
Advertisement
Advertisement

Moolec Science Regains Nasdaq Compliance After Strengthening Equity Base

Story Highlights
  • Moolec Science regained Nasdaq listing compliance in May 2026 by meeting minimum stockholders’ equity requirements within the panel’s remediation period.
  • Unaudited figures show equity rising to $15.2 million by March 31, 2026, reducing delisting risk despite a still highly leveraged balance sheet for the agri-biotech firm.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Moolec Science Regains Nasdaq Compliance After Strengthening Equity Base

Meet Samuel – Your Personal Investing Prophet

Moolec Science ( (MLEC) ) has shared an update.

On May 13, 2026, Moolec Science SA announced that it has regained compliance with all Nasdaq Capital Market continued listing requirements related to minimum stockholders’ equity within the remediation period granted by a Nasdaq Hearings Panel. The company reported stockholders’ equity of about $11.3 million as of December 31, 2025 and approximately $15.2 million as of March 31, 2026, supported by preference share conversions and related-party credit line disbursements, easing near-term delisting risk and providing greater balance sheet stability for shareholders.

The disclosed unaudited preliminary balance sheet shows total assets of roughly $104 million and liabilities of about $93 million as of March 31, 2026, including significant borrowings and convertible notes. While leverage remains elevated, the demonstrated equity improvement and derecognition of certain investments underpin Nasdaq compliance and may help Moolec preserve market access and investor confidence as it continues to scale its business in the competitive agri-biotech sector.

Spark’s Take on MLEC Stock

According to Spark, TipRanks’ AI Analyst, MLEC is a Neutral.

The score is held down primarily by weak financial health—large losses, continued cash burn, and a materially weakened capital structure with negative equity and elevated debt. Technicals are moderately supportive with improving intermediate momentum, but valuation remains constrained by unprofitability and no dividend support.

To see Spark’s full report on MLEC stock, click here.

More about Moolec Science

Moolec Science SA is an agrifood biotechnology company focused on molecular farming, using plants to produce animal proteins and other functional ingredients for the food industry. Listed on the Nasdaq Capital Market, the company targets alternative protein and sustainable food markets, positioning itself at the intersection of agtech and food-tech innovation.

Average Trading Volume: 486,231

Technical Sentiment Signal: Sell

Current Market Cap: $6.38M

For a thorough assessment of MLEC stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1